,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
Assessment and classification of patients with myocardial injury and infarction in clinical practice, Heart, vol.103, issue.1, pp.10-18, 2017. ,
Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, vol.116, pp.2634-53, 2007. ,
The effect of hemolysis on current troponin assays--a confounding preanalytical variable?, Clin Chem, vol.56, issue.7, pp.1195-1202, 2010. ,
Myocyte turnover in the aging human heart, Circ Res, vol.107, issue.11, pp.1374-86, 2010. ,
, The 99th Percentile of Reference Population for cTnI and cTnT Assay: Methodology, Pathophysiology and Clinical Implications, PubMed Journals, 2009.
Cardiac troponin I concentration is commonly increased in nondialysis patients with CKD: experience with a sensitive assay, Am J Kidney Dis Off J Natl Kidney Found, vol.49, issue.4, pp.507-523, 2007. ,
Origin of Cardiac Troponin T Elevations in Chronic Kidney Disease. Circulation, vol.136, pp.1073-1078, 2017. ,
Diurnal Rhythm of Cardiac Troponin: Consequences for the Diagnosis of Acute Myocardial Infarction, Clin Chem, vol.62, issue.12, pp.1602-1613, 2016. ,
Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events, Clin Chem, vol.55, issue.5, pp.930-937, 2009. ,
Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periods, Clin Chem, vol.57, issue.7, pp.1068-71, 2011. ,
Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation, Pflugers Arch, vol.455, issue.6, pp.979-86, 2008. ,
Cardiac troponin-I and risk of heart failure: a community-based cohort study, Eur Heart J, 2009. ,
Troponin Elevation in Heart Failure: Prevalence, Mechanisms, and Clinical Implications, J Am Coll Cardiol, vol.56, issue.14, pp.1071-1079, 2010. ,
Raised cardiac troponin in intensive care patients with sepsis, in the absence of angiographically documented coronary artery disease: A systematic review, J Intensive Care Soc, vol.16, issue.1, pp.52-59, 2015. ,
Mechanisms in neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage, Neurocrit Care, vol.5, issue.3, pp.243-252, 2006. ,
Neurogenic Stress Cardiomyopathy After Aneurysmal Subarachnoid Hemorrhage. World Neurosurg, vol.83, pp.880-885, 2015. ,
DOI : 10.1016/j.wneu.2015.01.013
URL : http://europepmc.org/articles/pmc4466211?pdf=render
Neurogenic stress cardiomyopathy associated with subarachnoid hemorrhage, Future Cardiol, vol.11, issue.1, pp.77-87, 2015. ,
Cardiac changes in epilepsy, Seizure, vol.19, issue.8, pp.455-60, 2010. ,
Sensitive troponin assay and the classification of myocardial infarction, Am J Med, vol.128, issue.5, pp.493-501, 2015. ,
Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury, Circulation, vol.137, issue.12, pp.1236-1281, 2018. ,
, , 2018.
Measurement of circulating concentrations of cardiac troponin I and T in healthy subjects: a tool for monitoring myocardial tissue renewal?, Clin Chem Lab Med, vol.47, issue.10, pp.1167-77, 2009. ,